Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Link

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
Cancer Immunology, Immunotherapy : CII|March 22, 2014
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancerRoheena Z Panni, Dominic E Sanford, Brian A Belt, et al.
Blood|October 29, 2014
Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in miceElise Peterson Lu, Michael McLellan, Li Ding, et al.
British Journal of Haematology|November 22, 2007
Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropeniaPhilip S Rosenberg, Blanche P Alter, Daniel C Link, et al.
Blood|March 28, 2009
Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activityBenjamin J Capoccia, Debra L Robson, Krysta D Levac, et al.
Blood Advances|January 29, 2026
Synthetic lethality of decitabine plus ATR inhibition for TP53-mutated AMLJeremy T Baeten, Sumedha Agashe, Imene Tabet, et al.
Leukemia|December 7, 2021
Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cellsElisabeth R Wilson, Nichole M Helton, Sharon E Heath, et al.
Current Opinion in Hematology|November 27, 2014
The diversity of mutations and clinical outcomes for ELANE-associated neutropeniaVahagn Makaryan, Cornelia Zeidler, Audrey Anna Bolyard, et al.
Blood|June 11, 2021
Heterozygous variants of CLPB are a cause of severe congenital neutropeniaJulia T Warren, Ryan R Cupo, Peeradol Wattanasirakul, et al.
Cancer Research|May 5, 2018
<i>MIR142</i> Loss-of-Function Mutations Derepress ASH1L to Increase <i>HOXA</i> Gene Expression and Promote LeukemogenesisMaria C Trissal, Terrence N Wong, Juo-Chin Yao, et al.
Biomaterials|November 23, 2021
Organ-on-a-chip model of vascularized human bone marrow nichesDrew E Glaser, Matthew B Curtis, Peter A Sariano, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
Cancer Immunology, Immunotherapy : CII|March 22, 2014
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancerRoheena Z Panni, Dominic E Sanford, Brian A Belt, et al.
Blood|October 29, 2014
Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in miceElise Peterson Lu, Michael McLellan, Li Ding, et al.
British Journal of Haematology|November 22, 2007
Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropeniaPhilip S Rosenberg, Blanche P Alter, Daniel C Link, et al.
Blood|March 28, 2009
Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activityBenjamin J Capoccia, Debra L Robson, Krysta D Levac, et al.
Blood Advances|January 29, 2026
Synthetic lethality of decitabine plus ATR inhibition for TP53-mutated AMLJeremy T Baeten, Sumedha Agashe, Imene Tabet, et al.
Leukemia|December 7, 2021
Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cellsElisabeth R Wilson, Nichole M Helton, Sharon E Heath, et al.
Current Opinion in Hematology|November 27, 2014
The diversity of mutations and clinical outcomes for ELANE-associated neutropeniaVahagn Makaryan, Cornelia Zeidler, Audrey Anna Bolyard, et al.
Blood|June 11, 2021
Heterozygous variants of CLPB are a cause of severe congenital neutropeniaJulia T Warren, Ryan R Cupo, Peeradol Wattanasirakul, et al.
Cancer Research|May 5, 2018
<i>MIR142</i> Loss-of-Function Mutations Derepress ASH1L to Increase <i>HOXA</i> Gene Expression and Promote LeukemogenesisMaria C Trissal, Terrence N Wong, Juo-Chin Yao, et al.
Biomaterials|November 23, 2021
Organ-on-a-chip model of vascularized human bone marrow nichesDrew E Glaser, Matthew B Curtis, Peter A Sariano, et al.
Pageof 17